Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Dyax licenses antibody phage display libraries to Kadmon

July 28, 2011

BioWa and arGEN-X enter license agreement for Potelligent technology

July 28, 2011

Merck & Co. to acquire rights to intravenous vernakalant

July 27, 2011

Vical-Astellas licensing agreements effective for TransVax

July 26, 2011

Merck & Co. and Simcere sign agreement to establish joint venture in China

July 22, 2011

Taiho and Nordic Group to collaborate on Teysuno

July 21, 2011

Valeant enters into agreement for Canadian marketing and distribution rights to Zuacta

July 21, 2011

Shionogi to acquire nine marketed products from Victory Pharma

July 20, 2011

Cel-Sci and Teva Pharmaceutical extend Multikine licensing agreement

July 20, 2011

BrainStorm Cell Therapeutics and U.S. medical centers prepare for ALS trial collaboration

July 20, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.